Skip to main content
ConductScienceScienceDex

Lipka, Elke

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #1,904
Unclaimed recordClaim profile
  • Rising Star
  • Long-Funded
  • Top 10% Funded

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2010 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2023

Linked Award Amount
$2.9M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#1,904
By linked amount among FY2023 PIs
Earliest Year Loaded
2010
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Lipka, Elke. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Lipka, Elke as a PI. Multi-PI records show the full award amount for context.

  • 5R44AI129122-07R44Contact PI
    Microneedle Delivery of Zanamivir for the Treatment of Influenza Infections
    Tsrl, Inc.
    $999.6K
    award amount
  • 2R44AI134190-04A1R44Contact PI
    Development of MRS-2541, a methionyl-tRNA synthetase inhibitor, for Gram positive bacterial infections.
    Tsrl, Inc.
    $998.5K
    award amount
  • 5R44GM145103-02R44Contact PI
    Development of Synthetic High-Density Lipoproteins for Treatment of Sepsis
    Tsrl, Inc.
    $643.8K
    award amount
  • 1R44AI179506-01R44Contact PI
    Novel, Self-Applied MicroArray Patch (MAP) of Zanamivir for Treatment of the Flu
    Tsrl, Inc.
    $300K
    award amount

Award organization

Organizations that administered FY2023 awards listing Lipka, Elke as a PI.

FY2023 award administered by Tsrl, Inc. (MI).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2010
    First NIH Award
    Tsrl, Inc.
  2. 2014
    $500K Cumulative Funding
  3. 2015
    $1M Cumulative Funding
  4. 2015
    $2M Cumulative Funding
  5. 2015
    Entered Top 50% Nationally
    Ranked #4974
  6. 2015
    Entered Top 25% Nationally
    Ranked #4974
  7. 2017
    $5M Cumulative Funding
  8. 2017
    Entered Top 10% Nationally
    Ranked #1752
  9. 2020
    $10M Cumulative Funding

Explore further

Find collaborators for Lipka, Elke

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →